WO2001087908A3 - Haplotypes du gene ccr3 - Google Patents

Haplotypes du gene ccr3 Download PDF

Info

Publication number
WO2001087908A3
WO2001087908A3 PCT/US2001/016278 US0116278W WO0187908A3 WO 2001087908 A3 WO2001087908 A3 WO 2001087908A3 US 0116278 W US0116278 W US 0116278W WO 0187908 A3 WO0187908 A3 WO 0187908A3
Authority
WO
WIPO (PCT)
Prior art keywords
haplotypes
ccr3
gene
disclosed
ccr3 gene
Prior art date
Application number
PCT/US2001/016278
Other languages
English (en)
Other versions
WO2001087908A2 (fr
Inventor
Julie Y Choi
Amir Kazemi
Beena Koshy
Original Assignee
Genaissance Pharmaceuticals
Julie Y Choi
Amir Kazemi
Beena Koshy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Julie Y Choi, Amir Kazemi, Beena Koshy filed Critical Genaissance Pharmaceuticals
Priority to AU2001263307A priority Critical patent/AU2001263307A1/en
Publication of WO2001087908A2 publication Critical patent/WO2001087908A2/fr
Publication of WO2001087908A3 publication Critical patent/WO2001087908A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Theoretical Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

L'invention concerne des variants du gène (CCR3) du récepteur (motif C-C) de chemokine. Elle concerne aussi des génotypes variés, des haplotypes et des paires d'haplotypes du gène CCR3 qui existent dans la population générale des Etats-Unis. Elle concerne encore des compositions et des procédés d'haplotypage et/ou de génotypage du gène CCR3 chez un sujet. Elle concerne enfin des polynucléotides définis par les séquences des haplotypes décrits dans l'invention.
PCT/US2001/016278 2000-05-18 2001-05-18 Haplotypes du gene ccr3 WO2001087908A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001263307A AU2001263307A1 (en) 2000-05-18 2001-05-18 Haplotypes of the ccr3 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20519100P 2000-05-18 2000-05-18
US60/205,191 2000-05-18

Publications (2)

Publication Number Publication Date
WO2001087908A2 WO2001087908A2 (fr) 2001-11-22
WO2001087908A3 true WO2001087908A3 (fr) 2002-07-18

Family

ID=22761178

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/016278 WO2001087908A2 (fr) 2000-05-18 2001-05-18 Haplotypes du gene ccr3

Country Status (2)

Country Link
AU (1) AU2001263307A1 (fr)
WO (1) WO2001087908A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005106492A2 (fr) * 2004-04-30 2005-11-10 Bayer Healthcare Ag Diagnostic et traitement therapeutique des maladies associees au recepteur 3 de la chimiokine c-c (ccr3)

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
COMBADIERE ET AL.: "Cloning and functional expression of a human eosinophil CC chemokine receptor", J. BIOLOGICAL CHEMISTRY, vol. 270, no. 27, 14 July 1995 (1995-07-14), pages 16491 - 16494, XP001018021 *
DATABASE GENBANK [online] DAUGHERTY ET AL.: "Cloning, expression and characterizatin of the human eosinophil eotaxin receptor", XP002906575, accession no. NCBI Database accession no. U51241 *
FUKUNAGA ET AL.: "Genetic polymorphisms of CC chemokine receptor 3 in Japanese and British asthmatics", EUR. RESPIR. J., vol. 17, no. 1, January 2001 (2001-01-01), pages 59 - 63, XP002906576 *
J. EXP. MED., vol. 183, no. 5, 1996, pages 2349 - 2354 *
KATO ET AL.: "New variations of human CC-chemokine receptors CCR3 and CCR4", GENES AND IMMUNITY, vol. 1, November 1999 (1999-11-01), pages 97 - 104, XP002906577 *

Also Published As

Publication number Publication date
WO2001087908A2 (fr) 2001-11-22
AU2001263307A8 (en) 2001-11-26
AU2001263307A1 (en) 2001-11-26

Similar Documents

Publication Publication Date Title
WO2001090122A3 (fr) Haplotypes du gene ctla4
WO2001079229A3 (fr) Haplotypes du gene cxcr4
WO2002026764A3 (fr) Haplotypes du gene ccr6
WO2001087908A3 (fr) Haplotypes du gene ccr3
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2001077363A3 (fr) Haplotypes du gene impdh2
WO2002022651A3 (fr) Haplotypes du gene ccr8
WO2002050098A3 (fr) Haplotypes du gene du recepteur de la prolactine (prlr)
WO2002016399A3 (fr) Haplotypes du gene tacr1
WO2001087909A3 (fr) Haplotypes du gene aanat
WO2002032928A3 (fr) Haplotypes du gene hrh1
WO2002032924A3 (fr) Haplotypes du gene chrm5
WO2001077125A3 (fr) Haplotypes du gene ccr5
WO2001087904A3 (fr) Haplotypes du gene gpr4
WO2002020556A3 (fr) Haplotypes du gene gpr68
WO2002036609A3 (fr) Haplotypes du gene chrm4
WO2001090128A3 (fr) Haplotypes du gene gpr3
WO2002038587A3 (fr) Haplotypes du gene grm8
WO2001090124A3 (fr) Haplotypes du gene gpr31
WO2002026766A3 (fr) Haplotypes du gene sstr4
WO2001085742A3 (fr) Haplotypes du gene npy1r
WO2001096350A3 (fr) Haplotypes du gene grm3
WO2002002580A3 (fr) Haplotypes du gene etfb
WO2001090118A3 (fr) Haplotypes du gene edn2
WO2002032926A3 (fr) Haplotypes du gene ccbp2

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP